0.44
+0.029(+7.07%)
Currency In USD
| Previous Close | 0.41 |
| Open | 0.4 |
| Day High | 0.44 |
| Day Low | 0.4 |
| 52-Week High | 2.82 |
| 52-Week Low | 0.34 |
| Volume | 268,164 |
| Average Volume | 3.38M |
| Market Cap | 2.26M |
| PE | -0.1 |
| EPS | -4.51 |
| Moving Average 50 Days | 0.47 |
| Moving Average 200 Days | 1.04 |
| Change | 0.03 |
If you invested $1000 in Autonomix Medical, Inc. Common Stock (AMIX) since IPO date, it would be worth $4.33 as of March 01, 2026 at a share price of $0.439. Whereas If you bought $1000 worth of Autonomix Medical, Inc. Common Stock (AMIX) shares 1 year ago, it would be worth $184.41 as of March 01, 2026 at a share price of $0.439.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Publication Strategy and Scientific Validation
GlobeNewswire Inc.
Feb 25, 2026 1:30 PM GMT
CEO, Brad Hauser, discusses building clinical credibility through rigorous science and peer-reviewed engagement THE WOODLANDS, TX, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical de
Autonomix Medical Selected to Present New Long-Term Pain Mitigation Data in Pancreatic Cancer at SSO 2026 Annual Meeting in Podium Presentation
GlobeNewswire Inc.
Feb 19, 2026 1:30 PM GMT
THE WOODLANDS, TX, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that Clarke Wilkirson,
Autonomix Medical to Present Final Analysis on Pain Mitigation in Pancreatic Cancer at SIO 2026 Annual Scientific Meeting
GlobeNewswire Inc.
Jan 28, 2026 1:30 PM GMT
THE WOODLANDS, TX, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that final clinical dat